Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1968 1
1969 1
1970 1
1978 1
1986 1
1988 1
1989 5
1990 6
1992 2
1993 3
1994 3
1995 2
1996 2
1997 3
1998 2
1999 7
2000 3
2001 1
2002 2
2003 2
2004 3
2005 3
2006 2
2007 5
2008 8
2009 6
2010 5
2011 3
2012 7
2013 10
2014 14
2015 6
2016 4
2017 5
2018 16
2019 12
2020 7
2021 13
2022 11
2023 5
2024 6

Text availability

Article attribute

Article type

Publication date

Search Results

179 results

Results by year

Filters applied: . Clear all
Page 1
Showing results for madden g
Search for Malden G instead (2 results)
HIV-Associated Vacuolar Encephalomyelopathy.
Madden GR, Fleece ME, Gupta A, Lopes MBS, Heysell SK, Arnold CJ, Wispelwey B. Madden GR, et al. Open Forum Infect Dis. 2019 Oct 1;6(10):ofz366. doi: 10.1093/ofid/ofz366. Open Forum Infect Dis. 2019. PMID: 31419292 Free PMC article.
Editorial: Behavioral Addictions, Risk-Taking, and Impulsive Choice.
Bortolato M, Madden GJ. Bortolato M, et al. Among authors: madden gj. Front Behav Neurosci. 2022 May 9;16:924030. doi: 10.3389/fnbeh.2022.924030. eCollection 2022. Front Behav Neurosci. 2022. PMID: 35615567 Free PMC article. No abstract available.
Pavlovian learning and conditioned reinforcement.
Madden GJ, Mahmoudi S, Brown K. Madden GJ, et al. J Appl Behav Anal. 2023 Jun;56(3):498-519. doi: 10.1002/jaba.1004. Epub 2023 May 31. J Appl Behav Anal. 2023. PMID: 37254881
Effect of Subcutaneous Casirivimab and Imdevimab Antibody Combination vs Placebo on Development of Symptomatic COVID-19 in Early Asymptomatic SARS-CoV-2 Infection: A Randomized Clinical Trial.
O'Brien MP, Forleo-Neto E, Sarkar N, Isa F, Hou P, Chan KC, Musser BJ, Bar KJ, Barnabas RV, Barouch DH, Cohen MS, Hurt CB, Burwen DR, Marovich MA, Brown ER, Heirman I, Davis JD, Turner KC, Ramesh D, Mahmood A, Hooper AT, Hamilton JD, Kim Y, Purcell LA, Baum A, Kyratsous CA, Krainson J, Perez-Perez R, Mohseni R, Kowal B, DiCioccio AT, Geba GP, Stahl N, Lipsich L, Braunstein N, Herman G, Yancopoulos GD, Weinreich DM; COVID-19 Phase 3 Prevention Trial Team. O'Brien MP, et al. JAMA. 2022 Feb 1;327(5):432-441. doi: 10.1001/jama.2021.24939. JAMA. 2022. PMID: 35029629 Free PMC article. Clinical Trial.
Subcutaneous REGEN-COV Antibody Combination to Prevent Covid-19.
O'Brien MP, Forleo-Neto E, Musser BJ, Isa F, Chan KC, Sarkar N, Bar KJ, Barnabas RV, Barouch DH, Cohen MS, Hurt CB, Burwen DR, Marovich MA, Hou P, Heirman I, Davis JD, Turner KC, Ramesh D, Mahmood A, Hooper AT, Hamilton JD, Kim Y, Purcell LA, Baum A, Kyratsous CA, Krainson J, Perez-Perez R, Mohseni R, Kowal B, DiCioccio AT, Stahl N, Lipsich L, Braunstein N, Herman G, Yancopoulos GD, Weinreich DM; Covid-19 Phase 3 Prevention Trial Team. O'Brien MP, et al. N Engl J Med. 2021 Sep 23;385(13):1184-1195. doi: 10.1056/NEJMoa2109682. Epub 2021 Aug 4. N Engl J Med. 2021. PMID: 34347950 Free PMC article. Clinical Trial.
179 results